Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Pablo Winzer
ResearcherPublications, citations & collaboration network
Pablo Winzer is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 15 works, 433 citations, an h-index of 12 and an i10-index of 12.
15
Works
433
Citations
12
h-index
12
i10-index
IDs:OpenAlex
How has Pablo Winzer's publication output changed over time?
ScholarIQpublication output · 2014–2021
Output grew0% over the shown period — from 1 works in 2014 to 1 in 2021.
1
3
1
4
1
20142015201820202021
What are the most-cited papers on Pablo Winzer?
ScholarIQmost cited works
<i>In Vitro</i> and <i>In Vivo</i> Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum
Pablo Winzer, Joachim Müller, Adriana Aguado-Martínez, Mahbubur Rahman, Vreni Balmer, Vera Manser, Luis Miguel Ortega‐Mora, Kayode K. Ojo, Erkang Fan, Dustin J. Maly, Wesley C. Van Voorhis, Andrew Hemphill
Antimicrobial Agents and Chemotherapy. 201590 CitationsOPEN ACCESS
Neospora caninum Calcium-Dependent Protein Kinase 1 Is an Effective Drug Target for Neosporosis Therapy
Kayode K. Ojo, Molly C. Reid, Latha Kallur Siddaramaiah, Joachim Müller, Pablo Winzer, Zhongsheng Zhang, Katelyn R. Keyloun, Rama Subba Rao Vidadala, E.A. Merritt, Wim G. J. Hol, Dustin J. Maly, Erkang Fan, Wesley C. Van Voorhis, Andrew Hemphill
PLoS ONE. 201472 CitationsOPEN ACCESS
Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice
Joachim Müller, Adriana Aguado-Martínez, Vera Manser, Vreni Balmer, Pablo Winzer, Dominic Ritler, Isabel C. Hostettler, David Arranz-Solís, Luis Miguel Ortega‐Mora, Andrew Hemphill
S2502194167. 201548 CitationsOPEN ACCESS
In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts
Dennis Imhof, Nicoleta Anghel, Pablo Winzer, Vreni Balmer, Jessica Ramseier, Kai Pascal Alexander Hänggeli, Ryan Choi, Matthew A. Hulverson, Grant R. Whitman, Samuel L.M. Arnold, Kayode K. Ojo, Wesley C. Van Voorhis, J. Stone Doggett, Luis Miguel Ortega‐Mora, Andrew Hemphill
S2502194167. 202137 CitationsOPEN ACCESS
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases
Wesley C. Van Voorhis, Matthew A. Hulverson, Ryan Choi, Wenlin Huang, Samuel L.M. Arnold, Deborah A. Schaefer, Dana P. Betzer, Rama Subba Rao Vidadala, Sangun Lee, Grant R. Whitman, Lynn K. Barrett, Dustin J. Maly, Michael W. Riggs, Erkang Fan, Thomas J. Kennedy, Saul Tzipori, J. Stone Doggett, Pablo Winzer, Nicoleta Anghel, Dennis Imhof, Joachim Müller, Andrew Hemphill, Ignacio Ferre, Roberto Sánchez-Sánchez, Luis Miguel Ortega‐Mora, Kayode K. Ojo
S11852655. 202032 CitationsOPEN ACCESS
Related on ScholarIQ
University of Bern
Institution
<i>In Vitro</i> and <i>In Vivo</i> Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum
Paper
Neospora caninum Calcium-Dependent Protein Kinase 1 Is an Effective Drug Target for Neosporosis Therapy
Paper
Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice
Paper
In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts
Paper
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases
Paper